Results 221 to 230 of about 7,495,371 (267)

Corrigendum: Interpretation guidance for MHRA regulatory considerations for phage therapeutic products. [PDF]

Microbiology (Reading)
Coxon C, Bell E, Adriaenssens E, Clark J, Edwards J, Gohir T, Hodges F, Jones J, Rees C, Sansom A, Smith D, Sutton M, Trippett C, Turner D.   +13 more
europepmc   +1 more source

Commodity risk assessment of <i>Hamamelis mollis</i> plants from the UK. [PDF]

EFSA J
EFSA Panel on Plant Health (PLH), Civera AV, Baptista P, Berlin A, Chatzivassiliou E, Cubero J, Cunniffe N, de la Peña E, Desneux N, Di Serio F, Filipiak A, Gonthier P, Hasiów-Jaroszewska B, Jactel H, Landa BB, Maistrello L, Makowski D, Milonas P, Papadopoulos NT, Susi H, van der Gaag DJ, Debode J, Navas-Cortes JA, Kritikos C, Kormpi M, Papachristos D, Reppa C, Akrivou A, Antonatos S, Beris D, Schulz OM, Lombardo MF, Gardi C, Potting R.   +33 more
europepmc   +1 more source

Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol. [PDF]

BMJ Open
Fisher BA, Rowe A, Hodson C, Wilkhu M, Williams E, Turner E, Allard A, Blake T, Bombardieri M, Cope AP, Dubey S, Mankia K, Malley T, Moore O, Payne M, Plummer R, Tilby M, Tillett T, Wong E, Wu Y, Filer A, Pratt A, Pallan L, Homer V.   +23 more
europepmc   +1 more source

Exploring Healthy Ageing in Place for Roma Communities: Insights from Knowledge Café Workshops in the UK. [PDF]

J Cross Cult Gerontol
Woolrych R, Marinov A, Sixsmith J, Greenfields M, Cisneros R, Torak P, Hyde A, Morteanu C, Smolinska-Poffley G.   +8 more
europepmc   +1 more source